4
Changes in Ownership
Anebulo Pharmaceuticals, Inc. Filed Acc 0001209191-22-061091
Options or other derivatives
- Chief Executive Officer acquired 70,246 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| ALLEN SIMON Chief Executive Officer | 2022-12-09 | Grant or award · Stock Option (right to buy) | +70,246 | 70,246 | D | ||
Loading xslF345X03/doc4.xml…